Coenzyme A Stock Net Income
| PPII Stock | USD 0.0002 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Coenzyme A's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Net Loss | -139.3 K | -146.3 K | |
| Net Loss | -139.3 K | -146.3 K | |
| Net Loss | -139.3 K | -146.3 K |
Coenzyme | Net Income | Build AI portfolio with Coenzyme Stock |
Coenzyme A Company Net Income Analysis
Coenzyme A's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Coenzyme A Net Income | (154.78 K) |
Most of Coenzyme A's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Coenzyme A is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Coenzyme Operating Income
Operating Income |
|
Based on the recorded statements, Coenzyme A reported net income of (154,780). This is 100.05% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 100.03% higher than that of the company.
Coenzyme Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Coenzyme A's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Coenzyme A could also be used in its relative valuation, which is a method of valuing Coenzyme A by comparing valuation metrics of similar companies.Coenzyme A is currently under evaluation in net income category among its peers.
Coenzyme Fundamentals
| Operating Margin | (34.92) % | ||||
| Current Valuation | 397.18 K | ||||
| Shares Outstanding | 555.05 K | ||||
| Price To Sales | 0.0003 X | ||||
| Revenue | 325.46 K | ||||
| Gross Profit | 228.56 K | ||||
| EBITDA | (4.54 M) | ||||
| Net Income | (154.78 K) | ||||
| Cash And Equivalents | 35.53 K | ||||
| Cash Per Share | 0.07 X | ||||
| Total Debt | 419.28 K | ||||
| Current Ratio | 0.16 X | ||||
| Book Value Per Share | (1.14) X | ||||
| Cash Flow From Operations | (4 K) | ||||
| Earnings Per Share | (35.31) X | ||||
| Beta | 3.3 | ||||
| Market Capitalization | 111 | ||||
| Total Asset | 79.08 K | ||||
| Retained Earnings | (742.76 K) | ||||
| Net Asset | 79.08 K |
About Coenzyme A Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Coenzyme A's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coenzyme A using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coenzyme A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Coenzyme A Piotroski F Score and Coenzyme A Altman Z Score analysis. For more detail on how to invest in Coenzyme Stock please use our How to Invest in Coenzyme A guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coenzyme A. If investors know Coenzyme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Coenzyme A listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (35.31) | Revenue Per Share 2.652 | Quarterly Revenue Growth 0.268 |
The market value of Coenzyme A is measured differently than its book value, which is the value of Coenzyme that is recorded on the company's balance sheet. Investors also form their own opinion of Coenzyme A's value that differs from its market value or its book value, called intrinsic value, which is Coenzyme A's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coenzyme A's market value can be influenced by many factors that don't directly affect Coenzyme A's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Coenzyme A's value and its price as these two are different measures arrived at by different means. Investors typically determine if Coenzyme A is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coenzyme A's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.